Skip to main content
main-content

Obstetrics and gynaecology

Obstetrics and gynaecology

11-02-2019 | Oncology | News | Article

ART-conceived children not at increased risk for cancer

Children conceived using assisted reproductive technology do not have an increased cancer risk relative to either the general population or naturally conceived children of women with impaired fertility, shows a Dutch study with a long follow-up.

28-01-2019 | Rheumatology | News | Article

Women with RA should expect a reduced success rate after assisted reproduction

Women with rheumatoid arthritis have a significantly lower chance of having a live birth following assisted reproductive technology treatment than women without RA, researchers report in the Annals of the Rheumatic Diseases.

07-12-2018 | Oncology | News | Article

Polycystic ovary syndrome associated with increased cancer risk

Women with polycystic ovary syndrome may have an increased likelihood for developing cancer, although the excess risk appears to be primarily restricted to those who are premenopausal, indicates a population-based study.

22-10-2018 | Oncology | News | Article

Maintenance olaparib ‘big step forward’ for BRCA-mutated advanced ovarian cancer

Progression-free survival is significantly improved with the use of maintenance olaparib in women with newly diagnosed FIGO stage III or IV ovarian cancer and a BRCA1/2 mutation, shows the placebo-controlled SOLO1 trial.

11-09-2018 | Leukaemia | News | Article

Maternal hormonal contraceptive use linked to childhood non-lymphoid leukemia risk

The use of hormonal contraceptives just before and during pregnancy may significantly increase the risk for childhood non-lymphoid leukemia, Danish researchers report.

06-09-2018 | Rheumatology | News | Article

Increased risk for preterm delivery in women with RA and JIA

Women with rheumatoid arthritis and those with juvenile idiopathic arthritis have a significantly elevated risk for preterm delivery, according to a prospective cohort study published in Arthritis Care & Research.

17-08-2018 | Oncology | News | Article

Catch-up HPV vaccination supported in older adolescence

US researchers have found evidence to support catch-up vaccination against the human papillomavirus in women given their first dose in older adolescence.

15-08-2018 | Oncology | News | Article

Apatinib–etoposide shows promise in platinum-resistant ovarian cancer

Oral etoposide plus apatinib is associated with a good objective response rate and manageable toxicity in heavily pretreated Chinese women with platinum-resistant or refractory ovarian cancer, according to results of the phase II AEROC study.

03-08-2018 | Oncology | News | Article

‘Reassuring’ childbirth rate reported for Hodgkin lymphoma survivors

The birth rate for women who are relapse-free after treatment for Hodgkin lymphoma has risen in recent years, becoming comparable with that of the general population regardless of disease stage or treatment.

25-07-2018 | Oncology | News | Article

Assisted reproduction linked to increased breast and ovarian cancer risk

Women who undergo assisted reproduction may be at increased risk for in situ breast cancer, and invasive and borderline ovarian tumors, show results of a large, population-based study.

16-07-2018 | Rheumatology | News | Article

TNF inhibitor discontinuation during pregnancy associated with increased flare risk

Women with inflammatory arthritis who discontinue tumor necrosis factor inhibitor therapy during pregnancy may be at increased risk for flare, researchers report.

19-02-2018 | Gynaecological cancer | News | Article

Chemoradiotherapy benefits demonstrated in locally advanced cervical cancer

Cisplatin chemoradiotherapy significantly delays disease recurrence and improves survival compared with radiotherapy alone in women with stage IIIB squamous cell carcinoma of the cervix, phase III study data show.

14-12-2017 | Breast cancer | News | Article

Short-term GnRHa therapy may prevent breast cancer chemotherapy-related ovarian dysfunction

Temporary ovarian suppression with a gonadotropin-releasing hormone analog alongside neoadjuvant or adjuvant chemotherapy could help preserve ovarian function and fertility in premenopausal women with early-stage breast cancer, shows a pooled analysis.

11-08-2017 | Gynaecological cancer | News | Article

Olaparib tablets improve PFS in BRCA1/2 mutated relapsed ovarian cancer

Maintenance therapy with olaparib, given in the newer tablet formulation, significantly improves progression-free survival compared with placebo in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation, phase III trial data show.

27-07-2017 | HBV | News | Article

Maternal HBV infection raises preterm birth risk

Women with hepatitis B virus infection prior to becoming pregnant are significantly more likely to have a preterm birth than those without HBV, shows an analysis of a Chinese population-based cohort.

04-07-2017 | Rheumatology | News | Article

Increased surveillance recommended for pregnant women with JIA

Women with a juvenile idiopathic arthritis diagnosis are at increased risk for both maternal and infant complications during pregnancy and birth, show data from a nationwide Swedish study.

10-04-2017 | Oncology | News | Article

Surveillance warranted for pregnancies in adolescent, young adult cancer survivors

Adverse birth outcomes, specifically preterm births and infants with low birth weight, are more likely among adolescent and young adult cancer survivors than women without cancer, a US study shows.

20-03-2017 | Oncology | News | Article

Maternal, fetal outcomes of pregnancy in cancer in focus

Two independent studies shed light on the effects of pregnancy during cancer, one finding that pregnancy does not adversely affect the survival of women with breast cancer and the other showing an association between maternal cancer and an increased risk for stillbirth and neonatal mortality.

23-01-2017 | Neurology | News | Article

Volume and location key to predicting preterm neonate WM injury outcomes

Predicting adverse motor and cognitive outcomes in preterm neonates with white matter injury requires the mapping of both lesion volume and location, suggests a magnetic resonance imaging study.

18-01-2017 | Neurology | News | Article

Folic acid supplement recommendation for neural tube defects upheld

The US Preventive Services Task Force has reaffirmed its 2009 recommendation that women who are planning or capable of pregnancy should take a daily supplement containing 400 µg to 800 µg of folic acid for the prevention of neural tube defects.

image credits